GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ACOR
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Acorda Therapeutics stock price ended at $0.661 on Wednesday, after losing 0%.
(Updated on Apr 17, 2024)

Hold candidate since Apr 15, 2024 PDF

No changes to the price of Acorda Therapeutics stock on the last trading day (Wednesday, 17th Apr 2024). During the last trading day the stock fluctuated 0% from a day low at $0.661 to a day high of $0.661. The price has fallen in 6 of the last 10 days and is down by -66.78% for this period.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at -$0.335 is broken, it will firstly indicate a stronger fall rate. Due to the high volatility and the trend direction we are not able to give forecast range for this stock.

Check out how to make money doing surveys! Ad

ACOR Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 11, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Acorda Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.744 and $8.86. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Buy
Special Signal Notification

Double Bottom Formation

Double Bottom Formation

Support, Risk & Stop-loss for Acorda Therapeutics stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 7.80%

Acorda Therapeutics is oversold on RSI14 (11). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: $0.616 (-6.78%) (This stock has low daily movements and this gives low risk. Low RSI14 is 11 which reduces the risk some. There is a buy signal from a pivot bottom found 4 days ago.)

Trading Expectations (ACOR) For The Upcoming Trading Day Of Thursday 18th

For the upcoming trading day on Thursday, 18th we expect Acorda Therapeutics to open at $0.661, and during the day (based on 14 day Average True Range), to move between -$0.120 and $1.44, which gives a possible trading interval of +/-$0.781 (+/-118.13%) up or down from last closing price. If Acorda Therapeutics takes out the full calculated possible swing range there will be an estimated 236.26% move between the lowest and the highest trading price during the day.

Is Acorda Therapeutics stock A Buy?

Acorda Therapeutics holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Acorda Therapeutics of Thursday, April 18, 2024

Fair opening price April 18, 2024 Current price
$0.661 ( 0%) $0.661

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ACOR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.661 .
R2 0.661 .
R1 0.661 .
Current price: 0.661
Support S1 0.661 .
S2 0.661 .
S3 0.661 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 0.661
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Acorda Therapeutics Stock and on which exchange is it traded?
The symbol for Acorda Therapeutics is ACOR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Acorda Therapeutics Stock?
Acorda Therapeutics holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Acorda Therapeutics Stock?
Acorda Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Acorda Therapeutics Stock.

What's the current price of Acorda Therapeutics Stock?
As of the end of day on the 2024-04-17, the price of an Acorda Therapeutics (ACOR) share was $0.661.

What is the 52-week high and low for Acorda Therapeutics Stock?
The 52-week high for Acorda Therapeutics Stock is $18.21 and the 52-week low is $0.449.

What is the market capitalization of Acorda Therapeutics Stock?
As of the 2024-04-17, the market capitalization of Acorda Therapeutics is 821.028K.

When is the next earnings date for Acorda Therapeutics?
The upcoming earnings date for Acorda Therapeutics is May 02, 2024.
Click to get the best stock tips daily for free!

About Acorda Therapeutics

Acorda Therapeutics Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops ARCUS p... ACOR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT